About CRO Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models. TechNavio's analysts forecast the Global CRO market to grow at a CAGR of 9.83 percent over the period 2014-2019. Covered in this Report The CRO market can be divided into two segments: Early-stage Development Services and Late-stage Development Services. To calculate the market size, the report considers the revenue generated from the sales of outsourcing... Research Beam Model: Research Beam Product ID: 169879 2500 USD New
Global CRO Market 2015-2019
 
 

Global CRO Market 2015-2019

  • Category : Healthcare
  • Published On : December   2014
  • Pages : 75
  • Publisher : Technavio
 
 
 
About CRO
Organizations that support outsourced research services for the Pharmaceutical, Biotechnology, and Medical Devices industries are called CROs. The nature of engagement of outsourced services is generally on contractual basis. This helps the vendors to control their R&D expenditure and concentrate on their core skills. CROs help vendors expand their capacities from clinical trials to healthcare regulatory submissions, biostatistics, and data management work. Furthermore, CROs have also started offering services at all phases (pre-clinical, phase I, phases II & IIIa, phases IIIb & IV, labs, and others) of drug development and discovery. CROs have built their capabilities from the earliest to the latest stages of drug development with emphasis on partnership, collaboration, and fee for service models.
TechNavio's analysts forecast the Global CRO market to grow at a CAGR of 9.83 percent over the period 2014-2019.
Covered in this Report
The CRO market can be divided into two segments: Early-stage Development Services and Late-stage Development Services. To calculate the market size, the report considers the revenue generated from the sales of outsourcing of R&D services to CROs by global pharmaceutical and biopharmaceutical vendors.
TechNavio's report, Global CRO Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global CRO market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Covance
• Parexel International
• PRA Health Sciences
• Quintiles Translational
Market Driver
• Increased Outsourcing of R&D Activities
• For a full, detailed list, view our report
Market Challenge
• Shortage of CRO Staff
• For a full, detailed list, view our report
Market Trend
• Increase in Number of M&A
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Service
07.1 Global Early Stage Development Services Market
07.1.1 Market Size and Forecast
07.2 Global Late Stage Development Services Market
07.2.1 Market Size and Forecast
08. Market Segmentation by Therapeutic Area
09. Geographical Segmentation
09.1 CRO Market in Americas
09.1.1 CRO Market in the US
09.2 CRO Market in EMEA Region
09.3 CRO Market in APAC Region
09.3.1 CRO Market in China
09.3.2 CRO Market in India
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Covance Inc.
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Product Portfolio by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Geographical Segmentation by Revenue 2013
18.1.7 Business Strategy
18.1.8 Recent Developments
18.1.9 SWOT Analysis
18.2 Quintiles Translational Corp.
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Product Portfolio by Revenue 2013
18.2.5 Business Segmentation by Revenue 2012 and 2013
18.2.6 Geographical Segmentation by Revenue 2013
18.2.7 Business Strategy
18.2.8 Recent Developments
18.2.9 SWOT Analysis
18.3 Parexel International Corp.
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Product Portfolio by Revenue 2013
18.3.5 Business Segmentation by Revenue 2012 and 2013
18.3.6 Geographical Segmentation by Revenue 2013
18.3.7 Business Strategy
18.3.8 Recent Developments
18.3.9 SWOT Analysis
18.4 PRA Health Sciences Inc.
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Product Portfolio by Revenue 2013
18.4.5 Business Segmentation by Revenue 2012 and 2013
18.4.6 Geographical Segmentation by Revenue 2013
18.4.7 Business Strategy
18.4.8 Recent Developments
18.4.9 SWOT Analysis
19. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: The Players in Clinical Research
Exhibit 3: Global CRO Market 2014-2019 (US$ billion)
Exhibit 4: Global CRO Market Segmentation by Type of Service
Exhibit 5: Global CRO Market Segmentation by Type of Service 2014
Exhibit 6: Global CRO Market Segmentation by Type of Activity 2014
Exhibit 7: Global Early Stage Development Services Market 2014-2019 (US$ billion)
Exhibit 8: Global Late Stage Development Services Market 2014-2019 (US$ billion)
Exhibit 9: Global CRO Market Segmentation by Type of Service 2014-2019 (US$ billion)
Exhibit 10: Global CRO Market Segmentation by Type of Service 2014-2019 (in Percent)
Exhibit 11: R&D Clinical Trial Pipeline by Therapeutic Area 2014
Exhibit 12: Global CRO Market by Geographical Segmentation 2014
Exhibit 13: Global CRO Market by Geographical Segmentation 2014-2019 (US$ billion)
Exhibit 14: Global CRO Market by Geographical Segmentation 2014-2019 (in Percent)
Exhibit 15: CRO Market in Americas 2014-2019 (US$ billion)
Exhibit 16: CRO Market in the US 2014-2019 (US$ billion)
Exhibit 17: CRO Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 18: CRO Market in APAC Region 2014-2019 (US$ billion)
Exhibit 19: CRO Market in China 2014-2019 (US$ billion)
Exhibit 20: CRO Market in India 2014-2019 (US$ billion)
Exhibit 21: Research Cost Comparison in US and India
Exhibit 22: Number of Drugs Going Off-patent in 2013-2016
Exhibit 23: Key Factors in Failure of Clinical Trials
Exhibit 24: Strategic Alliances Between Large Biopharma Companies And CRO's
Exhibit 25: Key Deals in the CRO and related services space
Exhibit 26: Global CRO Market by Vendor Segmentation 2014
Exhibit 27: Quintiles Market Sales by Segment 2013
Exhibit 28: Parexel International Segments
Exhibit 29: Percentage Market Share of Top 6 CRO's
Exhibit 24: Covance Inc.: Business Segmentation by Revenue 2013
Exhibit 25: Covance Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Covance Inc.: Sales by Geography 2013
Exhibit 24: Quintiles Translational Corp.: Business Segmentation by Revenue 2013
Exhibit 25: Quintiles Translational Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Quintiles Translational Corp.: Sales by Geography 2013
Exhibit 24: Parexel International Corp.: Business Segmentation by Revenue 2013
Exhibit 25: Parexel International Corp.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Parexel International Corp.: Sales by Geography 2013
Exhibit 24: PRA Health Sciences Inc.: Business Segmentation by Revenue 2013
Exhibit 25: PRA Health Sciences Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: PRA Health Sciences Inc.: Sales by Geography 2013

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT